Dimension gets $500M to bankroll biotech’s convergence with tech

Young biotech venture firm raises $500 million for its second fund

Dimension is capitalizing on the growing interest in AI startups in the biotech field.

Dimension raises $500M second fund for investing at the intersection tech and life sciences

Many VCs, particularly newer firms, readily admit that 2024 has been a challenging year for raising fresh capital. Dimension Capital, a two-year-old

Dimension gets $500M to bankroll biotech’s convergence with tech

The firm’s co-founders claim to be pursuing a “contrarian” approach, building a team versed in both computing and life sciences and concentrating resources on a smaller number of bets.

Dimension Capital said to strike $500m for second biotech, software fund - just two years after $350m debut fund close

Dimension Capital, a two-year-old venture capital firm targeting the intersection of software and biotech, has reportedly raised $500m for its oversubscribed sophomore fund. The post Dimension Capital said to strike $500m for second biotech, software fund – just two years after $350m debut fund close appeared first on AltAssets Private Equity News.

Dimension nabs $500M second fund for 'still contrary' intersection of bio and machine learning

Dimension has crossed a key threshold. The VC firm's trio of New York and Bay Area managing partners has raised a sophomore fund in the arduous field of life sciences investing. That group — Zavain Dar ...